Related Experiment Video
Updated: Oct 30, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Importance of Internal Variability in Clinical Trials of Cardiovascular Disease
Grant W Reed1, Parth Parikh1, Steven Nissen1
1Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Insights
Understanding internal variability is crucial for robust cardiovascular clinical trials. Minimizing variability through meticulous standardization and adjudication enhances the internal validity of randomized controlled trial results.
Area of Science:
- Cardiovascular Medicine
- Clinical Trial Methodology
Background:
- Randomized controlled trials (RCTs) are vital in cardiovascular medicine.
- Internal variability in clinical trials is poorly understood, impacting study reliability.
- Variability can stem from individual factors, measurement, sampling, or trial conduct.
Purpose of the Study:
- To clarify the concept of internal variability in clinical trials.
- To differentiate internal variability from internal validity.
- To provide a roadmap for minimizing internal variability and maximizing internal validity in RCTs.
Main Methods:
- Discusses steps to minimize internal variability in clinical trials.
- Highlights the importance of a meticulous adjudication process.
- Emphasizes standardization across all trial steps to ensure consistency.
Main Results:
- Internal variability can be introduced at multiple levels within a trial.
- Standardization and careful adjudication are key to reducing variability.
- Minimizing variability is essential for achieving sound methodology and internal validity.
Conclusions:
- Effective management of internal variability is critical for the integrity of cardiovascular RCTs.
- Standardized procedures and rigorous adjudication are recommended to enhance study validity.
- Addressing internal variability improves the accuracy and reliability of clinical trial findings.
Abstract:
A well conducted randomised controlled trial (RCT) is extremely important in the field of cardiovascular medicine. At the same time, it is equally important to understand the strengths and limitations of any RCT, and internal variability is a concept in clinical trials that is poorly understood. Variability in a clinical trial may be introduced at an individual level or during measurement, sampling, or conduct of the trial. It is not the same as internal validity, which is a broader concept of accuracy; to be valid, a study should minimise variability and have sound methodology. There are various steps that may be followed to minimise the internal variability in a clinical trial. One aspect of great importance is the adjudication process, which should be done meticulously and is often a step that is overlooked. It is important to standardise each step as much as possible, to ensure consistency and reduce noise at all levels. The concepts discussed in this review may serve as a roadmap to limit the influence of internal variability and maximise internal validity of RCT results.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
02:47Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Related Concept Videos
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Dosage Regimen: Individualization
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Regression Toward the Mean